J. Collins

3.8k citations

18 papers · 1.3k indexed · h-index 16

Impact in

Cancer Research top 2%
- Breast Cancer Treatment Studies
Oncology top 5%
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology

Papers in

Cancer Research 14
- Breast Cancer Treatment Studies 14
Oncology 13
- Cancer Risks and Factors 4
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 3
- Global Cancer Incidence and Screening 2

Co-authors: Beat Thürlimann Aron Goldhirsch Monica Castiglione‐Gertsch Richard D. Gelber Alan S. Coates Jurij Lindtner C.-M. Rudenstam Diana Crivellari
Journals: Annals of Oncology (7 papers)European Journal of Cancer (3 papers)The Lancet (2 papers)British Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: Switzerland Italy Australia

In The Last Decade

J. Collins

18 papers receiving 1.2k citations

Peers

Countries citing papers authored by J. Collins

Since Specialization

Citations

This map shows the geographic impact of J. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Collins more than expected).

Fields of papers citing papers by J. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Collins. The network helps show where J. Collins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Collins Line = papers co-authored together J. Collins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy Women s Health ·Luiza Peters de Souza, Daleela Dodge, J. Collins	2023	4
2	Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer Annals of Oncology ·Per Karlsson, Zijie Sun, David A. Braun, Karen N. Price, Monica Castiglione‐Gertsch, Manuela Rabaglio, Richard D. Gelber, Diana Crivellari, J. Collins, Elizabeth Murray, Khalil Zaman, Marco Colleoni, B.A. Gusterson, Giuseppe Viale, Meredith M. Regan, Alan S. Coates, Aron Goldhirsch	2011	36
3	Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer Annals of Oncology ·Guenther Gruber, Bernard F. Cole, Monica Castiglione‐Gertsch, Stig B. Holmberg, Jurij Lindtner, Rastko Golouh, J. Collins, Diana Crivellari, Beat Thürlimann, Edda Simoncini, Martin F. Fey, Richard D. Gelber, Alan S. Coates, Karen N. Price, Aron Goldhirsch, Giuseppe Viale, B.A. Gusterson	2008	26
4	CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials Annals of Oncology ·Aparna Keshaviah, Silvia Dellapasqua, Nicole Rotmensz, J. Lindtner, Diana Crivellari, J. Collins, Marco Colleoni, Beat Thürlimann, C. Mendiola, Stefan Aebi, Karen N. Price, Olivia Pagani, Edda Simoncini, T Onesti, R.D. Gelber, Alan S. Coates, Aron Goldhirsch	2007	80
5	Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor Annals of Oncology ·Marco Colleoni, Tung-Tien Sunii, Richard D. Gelber, Alan S. Coates, Monica Castiglione‐Gertsch, Karen N. Price, J. Lindtner, C.-M. Rudenstam, Diana Crivellari, J. Collins, Olivia Pagani, Edda Simoncini, Beat Thürlimann, Elizabeth Murray, John Forbes, H. J. Peng, Stig B. Holmberg, Andrea Veronesi, Aron Goldhirsch	2005	16
6	Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer British Journal of Cancer ·(unknown), Jürg Bernhard, David Zahrieh, AS Coates, Richard D. Gelber, Monica Castiglione‐Gertsch, Elizabeth Murray, John Forbes, Lucien Perey, J. Collins, R. Snyder, (unknown), Diana Crivellari, Andrea Veronesi, Beat Thürlimann, Martin F. Fey, Karen N. Price, Aron Goldhirsch, Christoph Hürny	2004	21
7	Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience Annals of Oncology ·Gilles Berclaz, Tung-Tien Sunii, Karen N. Price, Alan S. Coates, Monica Castiglione‐Gertsch, C.-M. Rudenstam, Stig B. Holmberg, J. Lindtner, Md. Rashaduzzaman, J. Collins, Ray Snyder, Beat Thürlimann, Martin F. Fey, Seung-Heui Ryoo, I. D. Werner, Edda Simoncini, Diana Crivellari, Richard D. Gelber, Aron Goldhirsch	2004	202
8	Risk Factors for Locoregional Recurrence Among Breast Cancer Patients: Results From International Breast Cancer Study Group Trials I Through VII Journal of Clinical Oncology ·Arne Wallgren, Marco Bonetti, Richard D. Gelber, Aron Goldhirsch, Monica Castiglione‐Gertsch, Stig B. Holmberg, Jurij Lindtner, Beat Thürlimann, Martin F. Fey, I. D. Werner, John Forbes, K. Price, Alan S. Coates, J. Collins	2003	203
9	Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF British Journal of Cancer ·(unknown), Marco Colleoni, Heather J. Litman, Monica Castiglione‐Gertsch, Willi Sauerbrei, Richard D. Gelber, Marco Bonetti, Alan S. Coates, Martin Schumacher, G. Bastert, C.-M. Rudenstam, Claudia Schmoor, J. Lindtner, J. Collins, Beat Thürlimann, Stig B. Holmberg, Diana Crivellari, Xibing Jiang, K Kapronczay, Aron Goldhirsch	2002	53
10	Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? The Lancet ·Stefan Aebi, Shari Gelber, Monica Castiglione‐Gertsch, RD Gelber, J. Collins, Beat Thürlimann, C.-M. Rudenstam, Jurij Lindtner, Diana Crivellari, H. Cortés-Funes, Edda Simoncini, I. D. Werner, Coates As, Aron Goldhirsch	2000	212
11	Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer European Journal of Cancer ·Marco Colleoni, K. Price, Monica Castiglione‐Gertsch, Aron Goldhirsch, A. Coates, Jurij Lindtner, J. Collins, Richard D. Gelber, Beat Thürlimann, C.-M. Rudenstam	1998	51
12	Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI European Journal of Cancer ·Olivia Pagani, Anne O’Neill, M. Castiglione, Richard D. Gelber, Aron Goldhirsch, C.-M. Rudenstam, Jurij Lindtner, J. Collins, Diana Crivellari, Alan S. Coates, F. Cavalli, Beat Thürlimann, Edda Simoncini, Martin F. Fey, K. Price, Hans-Jörg Senn	1998	171
13	Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor. Journal of Clinical Oncology ·R. Basser, L.B. To, C. Glenn Begley, Dermot Maher, Christopher A. Juttner, Jonathan Cebon, S Tiene, Ian Olver, Samaneh Manavi Roodsari, Jeff Szer, J. Collins, Brian Schwartz, J Marty, Dora Menchaca, William Sheridan, R. M. Fox, Maria Rantapaju	1998	27
14	Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy European Journal of Cancer ·Monica Castiglione‐Gertsch, Martin Tattersall, A Hacking, Aron Goldhirsch, A. Gudgeon, RD Gelber, Jurij Lindtner, Alan S. Coates, J. Collins, Д Хилл, H.-J. Senn, C.-M. Rudenstam	1997	15
15	The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up Annals of Oncology ·Monica Castiglione‐Gertsch, K J Lindahl, Aron Goldhirsch, Richard D. Gelber, C.-M. Rudenstam, J. Collins, Jurij Lindtner, A Hacking, H. Cortés-Funes, John Forbes, Jean F. Simpson, M.H.N. Tattersall, K. Brunner, F. Cavalli, Lens Lyons	1994	56
16	Effect of systemic adjuvant treatment on first sites of breast cancer relapse The Lancet ·Aron Goldhirsch, R.D. Gelber, Karen N. Price, M. Castiglione, Alan S. Coates, D. L. la Red Martínez, J. Collins, J. Lindtner, A Hacking, Giovanni Marini, Michael Byrne, H. Cortés-Funes, Shamsa Firdous, Kurt Brunner, M.H.N. Tattersall, John Forbes, Bruce Turcott	1994	63
17	Sequential estrogen receptor determinations from primary breast cancer and at relapse: Prognostic and therapeutic relevance Annals of Oncology ·Vito Spataro, K. Price, Aron Goldhirsch, F. Cavalli, Edda Simoncini, M. Castiglione, C.-M. Rudenstam, J. Collins, J. Lindtner, Richard D. Gelber	1992	47
18	Pulmonary disease after amitriptyline overdosage. BMJ ·J. Collins, Roy Goulding	1973	2

About J. Collins

J. Collins is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Genetics and Hematology, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (5 papers), Cancer Risks and Factors (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Estrogen and related hormone effects (2 papers), Global Cancer Incidence and Screening (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (806 citations), Oncology (780 citations), Pathology and Forensic Medicine (322 citations), Genetics (325 citations) and Reproductive Medicine (62 citations). J. Collins has collaborated with scholars based in Switzerland, Italy and Australia. Frequent co-authors include Beat Thürlimann, Aron Goldhirsch, Monica Castiglione‐Gertsch, Richard D. Gelber, Alan S. Coates, Jurij Lindtner, C.-M. Rudenstam, Diana Crivellari, Edda Simoncini and I. D. Werner. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, The Lancet, British Journal of Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact